Variant report

Variant	nsv894973
Chromosome Location	chr10:26020424-26043071
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr10:26020442..26022005-chr10:26023393..26025728,2	K562	blood:
2	chr10:26020442..26022005-chr10:26023393..26025728,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-GPR158-2	chr10:26020550-26021864	NONHSAT011808
2	lnc-GPR158-2	chr10:26020550-26021864	NR_108067

Extended variants
information (count: 616 )
Associated
traits (count: 40 )

Variant overlapped rSNPs/rCNVs (count:616 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs557584926	chr10:26020567-26020568	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
2	rs377649833	chr10:26020579-26020580	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
3	rs71495481	chr10:26020584-26020585	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
4	rs2505450	chr10:26020615-26020616	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
5	rs528154059	chr10:26020625-26020626	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
6	rs563599165	chr10:26020655-26020656	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
7	rs564555298	chr10:26020661-26020662	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
8	rs530385625	chr10:26020673-26020674	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
9	rs181780463	chr10:26020716-26020717	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
10	rs567550840	chr10:26020791-26020792	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
11	rs529890515	chr10:26020812-26020813	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
12	rs2367888	chr10:26020824-26020825	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
13	rs566518572	chr10:26020868-26020869	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
14	rs551327700	chr10:26020871-26020872	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
15	rs2504206	chr10:26020903-26020904	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
16	rs143778138	chr10:26020918-26020919	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
17	rs146460488	chr10:26020919-26020920	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
18	rs187436262	chr10:26020927-26020928	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
19	rs367928608	chr10:26021018-26021019	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
20	rs189955112	chr10:26021029-26021030	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
21	rs182185497	chr10:26021056-26021057	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
22	rs557409055	chr10:26021068-26021069	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
23	rs186268253	chr10:26021104-26021105	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
24	rs140868600	chr10:26021109-26021110	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
25	rs72781638	chr10:26021174-26021175	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
26	rs553554116	chr10:26021216-26021217	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
27	rs9663691	chr10:26021224-26021225	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
28	rs9663692	chr10:26021265-26021266	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
29	rs573068424	chr10:26021279-26021280	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
30	rs190241847	chr10:26021296-26021297	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
31	rs182581835	chr10:26021297-26021298	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
32	rs530473591	chr10:26021328-26021329	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
33	rs544189302	chr10:26021386-26021387	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
34	rs201426010	chr10:26021441-26021442	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
35	rs117021151	chr10:26021528-26021529	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
36	rs77711731	chr10:26021529-26021530	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
37	rs144609956	chr10:26021532-26021533	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
38	rs566680516	chr10:26021566-26021567	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
39	rs368521919	chr10:26021585-26021586	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
40	rs79099395	chr10:26021639-26021640	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
41	rs551951836	chr10:26021640-26021641	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
42	rs571759412	chr10:26021675-26021676	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
43	rs199655970	chr10:26021720-26021721	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
44	rs558473053	chr10:26021733-26021734	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
45	rs78740437	chr10:26021735-26021736	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
46	rs201441186	chr10:26021736-26021737	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
47	rs189720773	chr10:26021769-26021770	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
48	rs115359791	chr10:26021805-26021806	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
49	rs536968603	chr10:26021819-26021820	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
50	rs553350581	chr10:26021844-26021845	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:40)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
small cell lung cancer	20016488	CNVD
Behavioral abnormalities	21522184	CNVD
Dysmorphic features	21522184	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Autism	21439084	CNVD
Maculopathy	20981449	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21525872	CNVD
Adrenocortical carcinoma	18281524	CNVD

Chromatin state (count:37 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:26030400-26031200	Enhancers	Brain Germinal Matrix	brain
2	chr10:26031200-26035400	Weak transcription	Brain Germinal Matrix	brain
3	chr10:26034400-26035200	Enhancers	Pancreatic Islets	Pancreatic Islet
4	chr10:26034600-26036600	Enhancers	NH-A	brain
5	chr10:26034800-26035400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
6	chr10:26034800-26036600	Enhancers	Cortex derived primary cultured neurospheres	brain
7	chr10:26035000-26035400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
8	chr10:26035000-26036200	Enhancers	HUES6 Cell Line	embryonic stem cell
9	chr10:26035000-26036400	Enhancers	ES-I3 Cell Line	embryonic stem cell
10	chr10:26035000-26036400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr10:26035200-26036000	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
12	chr10:26035200-26036400	Enhancers	H1 Cell Line	embryonic stem cell
13	chr10:26035200-26036600	Enhancers	HUES64 Cell Line	embryonic stem cell
14	chr10:26035400-26036200	Enhancers	Brain Germinal Matrix	brain
15	chr10:26035400-26036600	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
16	chr10:26035600-26036400	Enhancers	HUES48 Cell Line	embryonic stem cell
17	chr10:26035800-26036400	Enhancers	iPS-18 Cell Line	embryonic stem cell
18	chr10:26035800-26036400	Enhancers	iPS-20b Cell Line	embryonic stem cell
19	chr10:26036000-26036400	Enhancers	iPS-15b Cell Line	embryonic stem cell
20	chr10:26036000-26037000	Weak transcription	Pancreatic Islets	Pancreatic Islet
21	chr10:26037000-26038200	Enhancers	Pancreatic Islets	Pancreatic Islet
22	chr10:26038200-26046400	Weak transcription	Pancreatic Islets	Pancreatic Islet
23	chr10:26038800-26044800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
24	chr10:26041000-26045000	Enhancers	Primary monocytes fromperipheralblood	blood
25	chr10:26041400-26041800	Enhancers	Monocytes-CD14+_RO01746	blood
26	chr10:26041800-26042000	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
27	chr10:26042000-26042600	Enhancers	Monocytes-CD14+_RO01746	blood
28	chr10:26042400-26043600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
29	chr10:26042600-26043000	Active TSS	Monocytes-CD14+_RO01746	blood
30	chr10:26042600-26043200	Enhancers	ES-I3 Cell Line	embryonic stem cell
31	chr10:26042600-26043200	Enhancers	iPS-20b Cell Line	embryonic stem cell
32	chr10:26042800-26043200	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr10:26042800-26043200	Enhancers	iPS-18 Cell Line	embryonic stem cell
34	chr10:26042800-26043200	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
35	chr10:26042800-26051000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
36	chr10:26043000-26043400	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
37	chr10:26043000-26043600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links